ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1712

Monocytic Angiotensin and Endothelin Receptor Imbalance Determines Secretion of the Profibrotic Chemokine Ligand CCL18

Judith Rademacher1, Jeannine Guenther2, Angela Kill3, Elise Siegert4 and Gabriela Riemekasten5, 1Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany, 10117 Berlin, Germany, 2Rheumatology/Clinical Immunology, Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany, Berlin, Germany, 3Rheumatology and clinical Immunology, Charité University Hospital, German Rheumatology Research Center, a Leibniz Institute, Berlin, Germany, 4Rheumatology and Clinical Immunology, Charité – University Hospital, Berlin, Germany, 5Charité University Hospital and German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Angiotensin, Autoantibodies and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics

Session Type: Abstract Submissions (ACR)

Background/Purpose

Circulating monocytes are progrenitor of extra-cellular matrix producing cells involved in fibrosis and show highest expression of angiotensin II (ATR) and endothelin receptors (ETR) compared to other peripheral blood mononuclear cell (PBMC) subsets(1, 2). Stimulating autoantibodies (aab) against AT1R and ETAR are elevated in patients with Systemic Sclerosis (SSc) and associated with mortality and the development of disease complications such as PAH, lung fibrosis and digital ulcers(3). SSc-IgG positive for Anti-AT1R and Anti-ETAR-aabs induces through the respective receptors the production of the profibrotic chemokine CCL18 in PBMCs(2).

We analysed whether effects of autoantibodies (aab) against angiotensinII receptor type 1 (AT1R) and endothelin receptor type A (ETAR) in patients with Systemic Sclerosis (SSc) might be influenced by expression of respective receptors and their functional counterparts AT2R and ETBR.

(1) Rasini E, et al. Regulatory peptides. 2006 May 15;134(2-3):69-74. PubMed PMID: 16530863.

(2) Gunther J, et al. Arthritis research & therapy. 2014 Mar 11;16(2):R65. PubMed PMID: 24612997.

(3) Riemekasten G, et al. Annals of the rheumatic diseases. 2011 Mar;70(3):530-6. PubMed PMID: 21081526.

Methods

AT1R, AT2R, ETAR and ETBR expression was measured on CD14+ monocytes of 29 SSc patients and 18 healthy donors by flow cytometry. PBMCs of 11 healthy donors were analyzed for receptor expression as well and in vitro stimulated with affinity purified IgG of SSc patients and normal controls. Afterwards, CCL18 concentration was measured in the supernatants by ELISA.

Results

Monocytes of SSc-patients presented higher expression of all 4 receptors compared to NC and an increased AT1R/AT2R ratio. ETAR/ETBR ratio was significantly reduced in patients with lung fibrosis and correlated negatively with the modified Rodnan Skin Score (Spearman rank correlation’s coefficient r=-0.49, p<0.01).

PBMCs stimulated with SSc-IgG showed higher CCL18 concentration in supernatants than PBMCs stimulated with NC-IgG (p<0.0001). CCL18 induction by NC-IgG and SSc-IgG correlated with AT1/AT2 ratio (SSc-IgG: r=0.72, p=0.03, NC-IgG: r=0.98; p<0.0001) and negatively with ETA/ETB ratio (SSc-IgG: r=-0.82, p=0.03, NC-IgG: r=-0.93; p=0.007) of receptor positive monocytes.

Conclusion

Receptor expression might reflect systemic activation of the angiotensin and endothelin system in SSc. Since patients with lung fibrosis and high mRSS showed a reduced ETAR/ETBR ratio, imbalance of ATR and ETR may influence effects of aab in SSc and could serve as a marker for disease complications. High AT1R/AT2R but low ETAR/ETBR ratios on monocytes correspond to higher secretion of CCL18 suggesting a link between receptor expression and monocytic function.


Disclosure:

J. Rademacher,
None;

J. Guenther,
None;

A. Kill,

Actelion Pharmaceuticals US,

2;

E. Siegert,
None;

G. Riemekasten,

Actelion Pharmaceuticals US,

2,

CellTrend,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/monocytic-angiotensin-and-endothelin-receptor-imbalance-determines-secretion-of-the-profibrotic-chemokine-ligand-ccl18/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology